标题
CD44v6 engages in colorectal cancer progression
作者
关键词
-
出版物
Cell Death & Disease
Volume 10, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-10
DOI
10.1038/s41419-018-1265-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2018) R Glynne-Jones et al. ANNALS OF ONCOLOGY
- Colorectal Cancer: Why Does Side Matter?
- (2018) Claire Gallois et al. DRUGS
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- Immunotherapy of Colon Cancer
- (2018) Alexander Stein et al. Oncology Research and Treatment
- Clinical Significance of CD44 Variants Expression in Colorectal Cancer
- (2018) Xiao-Dong Li et al. TUMORI
- MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms
- (2017) Sander P.J. Joosten et al. GASTROENTEROLOGY
- Intramucosal colorectal carcinoma with invasion of the lamina propria: a study by the Japanese Society for Cancer of the Colon and Rectum
- (2017) Motohiro Kojima et al. HUMAN PATHOLOGY
- The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study
- (2017) Jonna Berntsson et al. INTERNATIONAL JOURNAL OF CANCER
- Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
- (2017) Evgenia Karousou et al. MATRIX BIOLOGY
- Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance
- (2017) K A Whelan et al. ONCOGENE
- Molecular classification and precision therapy of cancer: immune checkpoint inhibitors
- (2017) Yingyan Yu Frontiers of Medicine
- What roles do colon stem cells and gap junctions play in the left and right location of origin of colorectal cancers?
- (2017) James E. Trosko et al. Journal of Cell Communication and Signaling
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies
- (2016) Min Fang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Intratumoral heterogeneity of CD44v6 in rectal cancer
- (2016) H.-G. Liu et al. Clinical & Translational Oncology
- Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling
- (2016) Alexandra Matzke-Ogi et al. GASTROENTEROLOGY
- Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks inex vivoculture
- (2016) Fanny Grillet et al. GUT
- Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells
- (2016) Lin Lv et al. TUMOR BIOLOGY
- MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer
- (2016) F. Pietrantonio et al. Cancer Discovery
- Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus
- (2015) René Adam et al. CANCER TREATMENT REVIEWS
- Is right-sided colon cancer different to left-sided colorectal cancer? – A systematic review
- (2015) G.H. Lee et al. EJSO
- Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
- (2015) Fotios Loupakis et al. JNCI-Journal of the National Cancer Institute
- Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer
- (2015) Bangli Hu et al. MEDICINE
- CD44v6 promotes β-catenin and TGF-β expression, inducing aggression in ovarian cancer cells
- (2015) JING WANG et al. Molecular Medicine Reports
- The genomic landscape of response to EGFR blockade in colorectal cancer
- (2015) Andrea Bertotti et al. NATURE
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Porcupine inhibitor suppresses paracrine Wnt-driven growth ofRnf43;Znrf3-mutant neoplasia
- (2015) Bon-Kyoung Koo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Different treatment strategies and molecular features between right-sided and left-sided colon cancers
- (2015) Hong Shen WORLD JOURNAL OF GASTROENTEROLOGY
- CD44v6 expression is associated with a poor prognosis in Chinese hepatocellular carcinoma patients: A meta-analysis
- (2015) Yong Fu et al. Clinics and Research in Hepatology and Gastroenterology
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
- (2015) Fotios Loupakis et al. JNCI-Journal of the National Cancer Institute
- Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)
- (2014) J. Goldstein et al. ANNALS OF ONCOLOGY
- Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
- (2014) E. Missiaglia et al. ANNALS OF ONCOLOGY
- Perspectives of CD44 targeting therapies
- (2014) V. Orian-Rousseau et al. ARCHIVES OF TOXICOLOGY
- Colon cancer: Cancer stem cells markers, drug resistance and treatment
- (2014) Zuzana Kozovska et al. BIOMEDICINE & PHARMACOTHERAPY
- Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type
- (2014) Z. Gatalica et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- Colorectal Cancer Stem Cells: From the Crypt to the Clinic
- (2014) Ann Zeuner et al. Cell Stem Cell
- Regulation of alternative splicing of CD44 in cancer
- (2014) Lubomir Prochazka et al. CELLULAR SIGNALLING
- The significance of autophagy in colorectal cancer pathogenesis and implications for therapy
- (2014) K Lai et al. JOURNAL OF CLINICAL PATHOLOGY
- Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma
- (2014) KAI CHEN et al. ONCOLOGY REPORTS
- CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance
- (2014) Jie Ni et al. PROSTATE
- Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis
- (2014) Hao Jiang et al. TUMOR BIOLOGY
- Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution
- (2014) S. Misale et al. Cancer Discovery
- The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets
- (2013) Malte Puchert et al. CELL AND TISSUE RESEARCH
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling
- (2013) J Zeilstra et al. ONCOGENE
- Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2013) Alberto Bardelli et al. Cancer Discovery
- A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers
- (2013) Russell C. Langan et al. Journal of Cancer
- FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk
- (2012) Alexandros Garouniatis et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD)
- (2012) Karl E. Miletti-González et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differential expression of CD133 based on microsatellite instability status in human colorectal cancer
- (2012) Jae Jun Park et al. MOLECULAR CARCINOGENESIS
- Osteopontin-Enhanced Hepatic Metastasis of Colorectal Cancer Cells
- (2012) Jianjin Huang et al. PLoS One
- Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis
- (2011) Zhiyong Mi et al. CARCINOGENESIS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Autophagy positively regulates the CD44+CD24-/lowbreast cancer stem-like phenotype
- (2011) Sílvia Cufí et al. CELL CYCLE
- Hyaluronan-CD44 interactions as potential targets for cancer therapy
- (2011) Suniti Misra et al. FEBS Journal
- Cytotoxic T lymphocyte migration and effector function in the tumor microenvironment
- (2011) Bettina Weigelin et al. IMMUNOLOGY LETTERS
- Integrating developmental signals: a Hippo in the (path)way
- (2011) A Mauviel et al. ONCOGENE
- Osteopontin Enhances the Expression and Activity of MMP-2 via the SDF-1/CXCR4 Axis in Hepatocellular Carcinoma Cell Lines
- (2011) Rihua Zhang et al. PLoS One
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles
- (2010) Minoo INTERNATIONAL JOURNAL OF ONCOLOGY
- Proteomic identification of CD44 interacting proteins
- (2010) Spyros S. Skandalis et al. IUBMB LIFE
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Is There a Difference in Survival Between Right- Versus Left-Sided Colon Cancers?
- (2008) Robert A. Meguid et al. ANNALS OF SURGICAL ONCOLOGY
- iASPP Inhibition: Increased Options in Targeting the p53 Family for Cancer Therapy
- (2008) H. S. Bell et al. CANCER RESEARCH
- Deletion of the WNT Target and Cancer Stem Cell Marker CD44 in Apc(Min/+) Mice Attenuates Intestinal Tumorigenesis
- (2008) J. Zeilstra et al. CANCER RESEARCH
- Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression
- (2008) Samuel Godar et al. CELL
- Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer
- (2008) I Zlobec et al. GUT
- The Effects of Myostatin on Adipogenic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells Are Mediated through Cross-communication between Smad3 and Wnt/β-Catenin Signaling Pathways
- (2008) Wen Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation